These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6211330)

  • 21. [Treatment of acute and chronic venous pathology of the extremities. Effect of mesoglycan in a case study of 50 patients].
    Florio A; Rosati V; Cioffi G
    Minerva Med; 1986 Oct; 77(41):1933-5. PubMed ID: 2946989
    [No Abstract]   [Full Text] [Related]  

  • 22. [Sulodexide in the treatment of venous thrombosis].
    Penka M
    Vnitr Lek; 1995 Mar; 41(3):169-71. PubMed ID: 7762172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in electroretractographic indices of the blood in patients with thrombophlebitis treated with fibrinolytic and anticoagulant agents].
    Previna AI; Pshukov SI
    Vestn Khir Im I I Grek; 1969 Oct; 103(10):70-4. PubMed ID: 5366654
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of a minor fibrinolytic drug (mesoglycan) in phlebitis].
    Scondotto G; De Fabritiis A; Guastarobba A; Amato AC; Filippini M
    Minerva Med; 1984 Jul; 75(28-29):1733-8. PubMed ID: 6236381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The conservative treatment of thrombophlebitis of the surface veins of the lower extremities].
    Kirienko AI; Koshkin VM
    Ter Arkh; 1995; 67(4):53-5. PubMed ID: 7784978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of fibrinolysis treatments of retinal venous thrombosis dependent on the duration of the disease].
    Metzler U; Oberhoffer G
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1977; 74():559-63. PubMed ID: 577778
    [No Abstract]   [Full Text] [Related]  

  • 27. Impending thrombosis of the central retinal vein.
    Bashat KM
    Bull Ophthalmol Soc Egypt; 1976; 69(73):465-8. PubMed ID: 1031107
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experience with fibrinolytic therapy in cases of deep vein thrombosis persisting over one week].
    Katona A; Deli L; Kiss E; Kander Z
    Orv Hetil; 1988 Jul; 129(31):1641-2, 1645-7. PubMed ID: 3076921
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study of the activity of a sulfomucopolysaccharide extractive on the blood-lipid and fibrinolytic pattern in atherosclerotic disease].
    Isidori A; Recchia O; Butti A
    Minerva Med; 1967 Mar; 58(19):779-82. PubMed ID: 4164416
    [No Abstract]   [Full Text] [Related]  

  • 30. ["How must deep leg venous thrombosis be diagnosed and treated?"].
    Bruhn HD
    Dtsch Med Wochenschr; 2003 Aug; 128(33):1730-1. PubMed ID: 12920673
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mesoglycan and fibrinolysis: therapeutic activity of oral mesoglycan in venous thrombosis. A short-term clinical, biological and instrumental study].
    Vittoria A; Cappelli R; Messa GL; Auteri A
    Minerva Med; 1986 Oct; 77(40):1867-72. PubMed ID: 2946002
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical study of the efficacy of mesoglycan in the treatment of venous diseases of the legs].
    Vercelloni M; Cogo R; Furcolo F; Monzani G; Casali W; Di Franco G
    Clin Ter; 1985 Nov; 115(3):173-6. PubMed ID: 2935355
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antiplatelet therapy in mitral stenosis].
    Muroi S
    J Cardiogr; 1983 Mar; 13(1):211. PubMed ID: 6644117
    [No Abstract]   [Full Text] [Related]  

  • 34. [Approach for the recovery of coronary blood flow by the patients with acute myocardial infarction].
    Golikov AP; Tebloev KI; Spasskiĭ AA; Zakharov SV; Mikhaĭlov AA
    Voen Med Zh; 2009 May; 330(5):47-54. PubMed ID: 19663209
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic potential of non-heparin glycosaminoglycans of natural origin.
    Bianchini P
    Semin Thromb Hemost; 1989 Oct; 15(4):365-9. PubMed ID: 2683090
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of the efficacy of profibrinolytic treatment with defibrotide in the therapy of thrombophlebitis].
    Murgiano GA
    Clin Ter; 1988 Dec; 127(5):355-61. PubMed ID: 2976633
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, Suleparoide.
    Callas DD; Hoppensteadt DA; Jeske W; Iqbal O; Bacher P; Ahsan A; Fareed J
    Semin Thromb Hemost; 1993; 19 Suppl 1():49-57. PubMed ID: 8362269
    [No Abstract]   [Full Text] [Related]  

  • 38. [Role of surgery in the treatment of thromboembolic disease and deep phlebitis of the legs. Apropos of 12 surgical cases].
    Desoutter P; Rouffet F; Lairy G; Lardoux H; Kohlmann G
    Sem Hop; 1982 Dec; 58(46):2713-7. PubMed ID: 6297071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Test with protamine sulfate in fibrinolytic treatment of myocardial infarct].
    Kocot E; Wolański A; Machalski M; Wodniecki J
    Pol Arch Med Wewn; 1973 Mar; 50(3):285-8. PubMed ID: 4692446
    [No Abstract]   [Full Text] [Related]  

  • 40. [Late results of fibrinolysis therapy of venous thrombosis].
    Breddin HK
    Verh Dtsch Ges Herz Kreislaufforsch; 1983; 49():201-8. PubMed ID: 6666302
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.